Kamran Ahmed discusses benefits, risks, and future guideline changes
— Kamran Ahmed discusses benefits, risks, and future guideline changes
by Gregory Laub, Senior Director, Video, MedPage Today
June 30, 2026
• 2 min read
At the American Society of Clinical Oncology (ASCO) meeting, a phase III trial was presented evaluating whether routine brain MRI surveillance can improve outcomes for patients with metastatic breast cancer and help guide future screening recommendations.
VIDEO: Sacituzumab govitecan delays subsequent therapy in breast cancer subset
VIDEO: GLP-1 use tied to significantly lower incidence of breast cancer
Lecanemab for Alzheimer's disease: Discussing risks and benefits is key
VIDEO: A-DREAM trial shows promising benefit of ADT interruption in prostate cancer
Experts discuss how advanced MRI is influencing surgical and radiation treatment decisions
Experts discuss adoption barriers, standardization, and smarter imaging use
Experts discuss biologic targeting, dose escalation, and the promise of precision radiotherapy
Guideline-concordant surveillance imaging has a significant association with improved survival for patients with non-small cell…
Question remains whether certain biomarkers will define patients who may benefit
Shimoli Barot discusses how OPTIMA may change treatment decisions
